CFS Investment Advisory Services, LLC

Position in PFE — Pfizer Inc

CIK 1845688 TOTOWA, NJ

Position in PFE

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$395,176

-$200,063 QoQ

Shares Held

16,411

-22.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#1,915

of 2,821 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFS Investment Advisory Services, LLC holds $28,816,926 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	29,062	$7,380,876
2	ABBV	AbbVie Inc.	24,175	$6,083,397
3	LLY	ELI LILLY & Co	4,838	$5,802,842
4	MRK	Merck & Co., Inc.	26,467	$3,401,009
5	AMGN	Amgen Inc	9,251	$3,349,972
6	GILD	Gilead Sciences, Inc.	11,660	$1,473,124
7	BMY	Bristol Myers Squibb Co	9,415	$542,492
8	PFE	Pfizer Inc This page	16,411	$395,176

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$395,176	16,411	-22.6%	Shares	Sole	2026-07-16
2026-03-31	$595,239	21,198	+2.4%	Shares	Sole	2026-04-29
2025-12-31	$515,579	20,706	-11.4%	Shares	Sole	2026-02-10
2025-09-30	$595,696	23,379	+0.3%	Shares	Sole	2025-10-31
2025-06-30	$565,179	23,316	-1.0%	Shares	Sole	2025-08-11
2025-03-31	$596,731	23,549	+3.6%	Shares	Sole	2025-05-12
2024-12-31	$602,761	22,720	-5.5%	Shares	Sole	2025-01-21
2024-09-30	$695,978	24,049	-50.3%	Shares	Sole	2024-11-12
2024-06-30	$1,353,336	48,368	-12.8%	Shares	Sole	2024-08-13
2023-06-30	$2,035,006	55,480	+143.5%	Shares	Sole	2023-07-21
2022-06-30	$1,194,669	22,786	-98.0%	Shares	Sole	2022-08-16
2022-03-31	$22,000	1,150,264	+4996.2%	Shares	Sole	2022-05-27
2021-12-31	$1,332,817	22,571	+4.6%	Shares	Sole	2022-02-14
2021-09-30	$928,198	21,581	+18.6%	Shares	Sole	2021-11-19
2020-12-31	$669,868	18,198	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.